Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer's disease. Tsaka G, Pages AM, De Sousa CB, Lammertyn J, et al. J Biol Chem 2026 Feb 3:111221. doi: 10.1016/j.jbc.2026.111221.

Read + Share

Amedeo Smart

Independent Medical Education

Tsaka G, Pages AM, De Sousa CB, Lammertyn J, et al. Conformation-specific monoclonal antibodies reveal early Tau structural intermediates in Alzheimer's disease. J Biol Chem 2026 Feb 3:111221. doi: 10.1016/j.jbc.2026.111221.
PMID: 41643771